-
Title
Dr.
-
Name
Paul Arnold
-
Group
Faculty
-
Degrees
MD, PhD, FRCPC
-
Rank
Assistant Professor
-
Division1
Child & Adolescent
-
Roles
Head, Anxiety Disorders Program, Department of Psychiatry, Hospital for Sick Children
Scientist, Genetics & Genome Biology Program, Hospital for Sick Children -
Institution
Hospital For Sick Children
-
Address
555 University Avenue
-
Room
1st floor Burton Wing, Dept of Psychiatry
-
City/Prov
Toronto, ON
-
Postal Code
M5G 1X8
-
Telephone
416-813-7530
-
Fax
416-813-5326
-
Profile
Dr. Arnold is a Staff Psychiatrist within the Department of Psychiatry at SickKids, and he is also the head of the Anxiety Disorders Program where he specializes in the assessment and pharmacological treatment of children with Obsessive-Compulsive Disorders (OCD).
-
Research Interests
Dr. Arnold’s research focuses on the genetics of childhood neuropsychiatric disorders, particularly childhood obsessive-compulsive disorder (OCD), and has been funded by major external grants from the Canadian Institutes of Health Research (CIHR) and the National Institutes of Health (NIH). He is a member of the international Steering Committee of the first Genome-wide Association Study (GWAS) of OCD.
Dr. Arnold’s work has resulted in a patent “SLC1A1 Marker for Anxiety Disorder”. Centre for Addiction and Mental Health. Inventors: James L. Kennedy, Paul D. Arnold, Margaret A. Richter. U.S. Patent No: 7,368,264 (Issued May 6, 2008)
-
Other Links
Selected Publications:
Arnold PD, MacMaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR: Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 172(2): 136-139 (2009) “Recommended” rating by Faculty of Medicine 1000”.
Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL: Glutamate transporter gene (SLC1A1) associated with obsessive-compulsive disorder. Archives of General Psychiatry. 63(7): 769-76. (2006).
Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl). 174(4): 530-538 (2004). Epub 2004 Apr 09.